Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K3JQ
|
|||
Former ID |
DIB014154
|
|||
Drug Name |
RPI-MN
|
|||
Synonyms |
Pepteron (oral, HIV), ReceptoPharm; RPI-MN (oral, HIV); RPI-MN (oral, HIV), ReceptoPharm
Click to Show/Hide
|
|||
Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Phase 1 | [1] | |
Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Phase 1 | [2] | ||
Company |
ReceptoPharm Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nicotinic acetylcholine receptor (nAChR) | Target Info | Antagonist | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.